
    
      This is a prospective, open-label study testing the ability to effectively communicate
      patient-specific clinical trial matching with kidney patients and clinician investigators.
      The study consists of four components:

        1. Recruitment of participants from the NEPTUNE observational cohort study

        2. Generation of participant profile-trial match assessment using data from the NEPTUNE
           observational study and profiling units by the NEPTUNE Molecular Nephrology Board

        3. Establishing and testing a framework to communicate disease-trial drug mechanism
           matching with investigators and patients

        4. Retrospective comparison of kidney health outcomes in subjects enrolled in trials that
           aligned with their match vs. trial subjects with mis-aligned or unknown match alignment.
    
  